143 related articles for article (PubMed ID: 8578822)
1. Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine.
Yoshikawa M; Sasakawa C; Okada N; Takasaka M; Nakayama M; Yoshikawa Y; Kohno A; Danbara H; Nariuchi H; Shimada H
Vaccine; 1995; 13(15):1436-40. PubMed ID: 8578822
[TBL] [Abstract][Full Text] [Related]
2. Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
Noriega FR; Wang JY; Losonsky G; Maneval DR; Hone DM; Levine MM
Infect Immun; 1994 Nov; 62(11):5168-72. PubMed ID: 7927802
[TBL] [Abstract][Full Text] [Related]
3. Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis.
Sansonetti PJ; Arondel J
Vaccine; 1989 Oct; 7(5):443-50. PubMed ID: 2683460
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
5. Development of an auxotrophic oral live Shigella flexneri vaccine.
Lindberg AA; Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP
Vaccine; 1988 Apr; 6(2):146-50. PubMed ID: 2838986
[TBL] [Abstract][Full Text] [Related]
6. [Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
Yang XF; Zhou L; Zheng J; Si LS; Wang YL
Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):748-52. PubMed ID: 16342769
[TBL] [Abstract][Full Text] [Related]
7. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
Kärnell A; Cam PD; Verma N; Lindberg AA
Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of living attenuated shigellae.
Serény B; Tenner C; Rácz P
Acta Microbiol Acad Sci Hung; 1971; 18(4):239-45. PubMed ID: 4950775
[No Abstract] [Full Text] [Related]
9. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
Kärnell A; Sweiha H; Lindberg AA
Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
[TBL] [Abstract][Full Text] [Related]
10. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
11. Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.
Bernardini ML; Arondel J; Martini I; Aidara A; Sansonetti PJ
Infect Immun; 2001 Feb; 69(2):1072-83. PubMed ID: 11160004
[TBL] [Abstract][Full Text] [Related]
12. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
[TBL] [Abstract][Full Text] [Related]
13. Regulated Delayed
Su H; Liu Q; Wang S; Curtiss R; Kong Q
Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
[No Abstract] [Full Text] [Related]
14. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
[TBL] [Abstract][Full Text] [Related]
16. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes.
Verma NK; Lindberg AA
Vaccine; 1991 Jan; 9(1):6-9. PubMed ID: 2008803
[TBL] [Abstract][Full Text] [Related]
17. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates.
Ranallo RT; Fonseka S; Boren TL; Bedford LA; Kaminski RW; Thakkar S; Venkatesan MM
Vaccine; 2012 Jul; 30(34):5159-71. PubMed ID: 22658966
[TBL] [Abstract][Full Text] [Related]
18. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.
Kotloff KL; Noriega F; Losonsky GA; Sztein MB; Wasserman SS; Nataro JP; Levine MM
Infect Immun; 1996 Nov; 64(11):4542-8. PubMed ID: 8890204
[TBL] [Abstract][Full Text] [Related]
19. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.
Venkatesan M; Fernandez-Prada C; Buysse JM; Formal SB; Hale TL
Vaccine; 1991 May; 9(5):358-63. PubMed ID: 1872021
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Barry EM; Wang J; Wu T; Davis T; Levine MM
Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
